Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 6c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• BMO Capital Reiterates Outperform Rating on CMS Energy (CMS)
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential